• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
HLA-G expression in melanoma: a way for tumor cells to escape from immunosurveillance.黑色素瘤中的HLA-G表达:肿瘤细胞逃避免疫监视的一种方式。
Proc Natl Acad Sci U S A. 1998 Apr 14;95(8):4510-5. doi: 10.1073/pnas.95.8.4510.
2
HLA-G expression in human melanoma cells: protection from NK cytolysis.人黑色素瘤细胞中的HLA - G表达:免受自然杀伤细胞溶解作用的保护。
J Reprod Immunol. 1999 Jul;43(2):183-93. doi: 10.1016/s0165-0378(99)00037-6.
3
The alpha1 domain of HLA-G1 and HLA-G2 inhibits cytotoxicity induced by natural killer cells: is HLA-G the public ligand for natural killer cell inhibitory receptors?HLA-G1和HLA-G2的α1结构域可抑制自然杀伤细胞诱导的细胞毒性:HLA-G是自然杀伤细胞抑制性受体的共同配体吗?
Proc Natl Acad Sci U S A. 1997 May 13;94(10):5249-54. doi: 10.1073/pnas.94.10.5249.
4
HLA-G in skin cancer: a wolf in sheep's clothing?皮肤癌中的HLA-G:披着羊皮的狼?
Hum Immunol. 2003 Nov;64(11):1073-80. doi: 10.1016/j.humimm.2003.08.351.
5
Switch of HLA-G alternative splicing in a melanoma cell line causes loss of HLA-G1 expression and sensitivity to NK lysis.黑色素瘤细胞系中HLA - G可变剪接的转换导致HLA - G1表达缺失及对NK细胞裂解的敏感性。
Int J Cancer. 2005 Oct 20;117(1):114-22. doi: 10.1002/ijc.21151.
6
HLA-G in melanoma: A new strategy to escape from immunosurveillance?黑色素瘤中的HLA-G:一种逃避免疫监视的新策略?
Onkologie. 2002 Apr;25(2):129-34. doi: 10.1159/000055222.
7
Human melanoma cell secreting human leukocyte antigen-G5 inhibit natural killer cell cytotoxicity by impairing lytic granules polarization toward target cell.人黑色素瘤细胞分泌的人白细胞抗原-G5 通过损害溶酶体颗粒向靶细胞的极化来抑制自然杀伤细胞的细胞毒性。
Hum Immunol. 2009 Dec;70(12):1000-5. doi: 10.1016/j.humimm.2009.07.019. Epub 2009 Aug 3.
8
Heterogeneity of HLA-G gene transcription and protein expression in malignant melanoma biopsies.恶性黑色素瘤活检中HLA - G基因转录和蛋白表达的异质性。
Cancer Res. 1999 Apr 15;59(8):1954-60.
9
MICA triggering signal for NK cell tumor lysis is counteracted by HLA-G1-mediated inhibitory signal.自然杀伤细胞肿瘤溶解的MICA触发信号被HLA-G1介导的抑制信号抵消。
Int J Cancer. 2002 Jul 1;100(1):63-70. doi: 10.1002/ijc.10460.
10
[HLA-G: a tolerance molecule implicated in the escape of tumors from immunosurveillance].[人类白细胞抗原G:一种与肿瘤逃避免疫监视相关的耐受分子]
Pathol Biol (Paris). 1999 Oct;47(8):766-70.

引用本文的文献

1
The TEA domain transcription factors TEAD1 and TEAD3 and WNT signaling determine HLA-G expression in human extravillous trophoblasts.TEA结构域转录因子TEAD1和TEAD3以及WNT信号通路决定人绒毛外滋养层细胞中HLA-G的表达。
Proc Natl Acad Sci U S A. 2025 Mar 25;122(12):e2425339122. doi: 10.1073/pnas.2425339122. Epub 2025 Mar 17.
2
Targeting of Non-Classical Human Leukocyte Antigens as Novel Therapeutic Strategies in Cancer.靶向非经典人类白细胞抗原作为癌症的新型治疗策略
Cancers (Basel). 2024 Dec 22;16(24):4266. doi: 10.3390/cancers16244266.
3
The efficacy and applicability of chimeric antigen receptor (CAR) T cell-based regimens for primary bone tumors: A comprehensive review of current evidence.嵌合抗原受体(CAR)T细胞疗法用于原发性骨肿瘤的疗效及适用性:当前证据的全面综述
J Bone Oncol. 2024 Sep 22;48:100635. doi: 10.1016/j.jbo.2024.100635. eCollection 2024 Oct.
4
HLA-G neo-expression modifies genetic programs governing tumor cell lines.HLA - G新表达改变调控肿瘤细胞系的遗传程序。
Cancer Immunol Immunother. 2024 Oct 3;73(12):247. doi: 10.1007/s00262-024-03768-5.
5
Analysis of HLA-G 14 bp Insertion/Deletion Polymorphism and HLA-G, ILT2 and ILT4 Expression in Head and Neck Squamous Cell Carcinoma Patients.头颈部鳞状细胞癌患者中HLA-G 14bp插入/缺失多态性及HLA-G、ILT2和ILT4表达的分析
Diseases. 2024 Feb 8;12(2):34. doi: 10.3390/diseases12020034.
6
Human leukocyte immunoglobulin-like receptors in health and disease.人类白细胞免疫球蛋白样受体在健康与疾病中的作用。
Front Immunol. 2023 Nov 13;14:1282874. doi: 10.3389/fimmu.2023.1282874. eCollection 2023.
7
Prognostic significance of HLA-G in patients with colorectal cancer: a meta-analysis and bioinformatics analysis.HLA-G 在结直肠癌患者中的预后意义:一项荟萃分析和生物信息学分析。
BMC Cancer. 2023 Oct 24;23(1):1024. doi: 10.1186/s12885-023-11522-w.
8
The Molecular Mechanisms of HLA-G Regulatory Function on Immune Cells during Early Pregnancy.HLA-G 对妊娠早期免疫细胞的调控作用的分子机制。
Biomolecules. 2023 Aug 3;13(8):1213. doi: 10.3390/biom13081213.
9
Prognostic value of human leukocyte antigen G expression in solid tumors: a systematic review and meta-analysis.人类白细胞抗原 G 表达在实体瘤中的预后价值:系统评价和荟萃分析。
Front Immunol. 2023 May 18;14:1165813. doi: 10.3389/fimmu.2023.1165813. eCollection 2023.
10
The Function of NK Cells in Tumor Metastasis and NK Cell-Based Immunotherapy.自然杀伤细胞在肿瘤转移中的作用及基于自然杀伤细胞的免疫疗法
Cancers (Basel). 2023 Apr 16;15(8):2323. doi: 10.3390/cancers15082323.

本文引用的文献

1
Natural killer cell lines kill autologous beta2-microglobulin-deficient melanoma cells: implications for cancer immunotherapy.自然杀伤细胞系可杀伤自体β2-微球蛋白缺陷的黑色素瘤细胞:对癌症免疫治疗的启示。
Proc Natl Acad Sci U S A. 1997 Nov 25;94(24):13140-5. doi: 10.1073/pnas.94.24.13140.
2
Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis.支持HLA - G在保护胎儿免受母体子宫自然杀伤细胞溶解作用中发挥作用的直接证据。
Proc Natl Acad Sci U S A. 1997 Oct 14;94(21):11520-5. doi: 10.1073/pnas.94.21.11520.
3
HLA-G recognition by human natural killer cells. Involvement of CD94 both as inhibitory and as activating receptor complex.人类自然杀伤细胞对HLA - G的识别。CD94作为抑制性和激活性受体复合物的参与情况。
Eur J Immunol. 1997 Aug;27(8):1875-80. doi: 10.1002/eji.1830270809.
4
CD94/NKG2 is the predominant inhibitory receptor involved in recognition of HLA-G by decidual and peripheral blood NK cells.CD94/NKG2是蜕膜和外周血自然杀伤细胞识别HLA-G所涉及的主要抑制性受体。
J Immunol. 1997 Aug 1;159(3):1072-5.
5
Uterine NK cells and trophoblast HLA class I molecules.子宫自然杀伤细胞与滋养层细胞的HLA I类分子
Am J Reprod Immunol. 1997 Jun;37(6):459-62. doi: 10.1111/j.1600-0897.1997.tb00260.x.
6
Synergy between tamoxifen and cisplatin in human melanoma cells is dependent on the presence of antiestrogen-binding sites.
Cancer Res. 1997 Jul 1;57(13):2657-60.
7
The CD94/NKG2-A inhibitory receptor complex is involved in natural killer cell-mediated recognition of cells expressing HLA-G1.CD94/NKG2-A抑制性受体复合物参与自然杀伤细胞介导的对表达HLA-G1细胞的识别。
J Immunol. 1997 Jun 15;158(12):5736-43.
8
The alpha1 domain of HLA-G1 and HLA-G2 inhibits cytotoxicity induced by natural killer cells: is HLA-G the public ligand for natural killer cell inhibitory receptors?HLA-G1和HLA-G2的α1结构域可抑制自然杀伤细胞诱导的细胞毒性:HLA-G是自然杀伤细胞抑制性受体的共同配体吗?
Proc Natl Acad Sci U S A. 1997 May 13;94(10):5249-54. doi: 10.1073/pnas.94.10.5249.
9
Natural killer cells: from no receptors to too many.自然杀伤细胞:从无受体到受体过多。
Immunity. 1997 Apr;6(4):371-8. doi: 10.1016/s1074-7613(00)80280-0.
10
HLA-G gene polymorphism segregation within CEPH reference families.HLA - G基因多态性在CEPH参考家系中的分离情况。
Hum Immunol. 1997 Apr 1;53(2):140-7. doi: 10.1016/S0198-8859(97)00038-4.

黑色素瘤中的HLA-G表达:肿瘤细胞逃避免疫监视的一种方式。

HLA-G expression in melanoma: a way for tumor cells to escape from immunosurveillance.

作者信息

Paul P, Rouas-Freiss N, Khalil-Daher I, Moreau P, Riteau B, Le Gal F A, Avril M F, Dausset J, Guillet J G, Carosella E D

机构信息

Direction des Sciences du Vivant-Department de Recherche Medicale, Service de Recherches en Hemato-Immunologie, Commissariat à l'Energie Atomique, Hôpital Saint-Louis, Centre Hayem, 1, Avenue Claude-Vellefaux, 75010 Paris, France.

出版信息

Proc Natl Acad Sci U S A. 1998 Apr 14;95(8):4510-5. doi: 10.1073/pnas.95.8.4510.

DOI:10.1073/pnas.95.8.4510
PMID:9539768
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC22520/
Abstract

Considering the well established role of nonclassical HLA-G class I molecules in inhibiting natural killer (NK) cell function, the consequence of abnormal HLA-G expression in malignant cells should be the escape of tumors from immunosurveillance. To examine this hypothesis, we analyzed HLA-G expression and NK sensitivity in human malignant melanoma cells. Our analysis of three melanoma cell lines and ex vivo biopsy demonstrated that (i) IGR and M74 human melanoma cell lines exhibit a high level of HLA-G transcription with differential HLA-G isoform transcription and protein expression patterns, (ii) a higher level of HLA-G transcription ex vivo is detected in a skin melanoma metastasis biopsy compared with a healthy skin fragment from the same individual, and (iii) HLA-G protein isoforms other than membrane-bound HLA-G1 protect IGR from NK lysis. It thus appears of critical importance to consider the specific role of HLA-G expression in tumors in the design of future cancer immunotherapies.

摘要

鉴于非经典HLA-G I类分子在抑制自然杀伤(NK)细胞功能方面已确立的作用,恶性细胞中HLA-G表达异常的后果应该是肿瘤逃避免疫监视。为了检验这一假设,我们分析了人类恶性黑色素瘤细胞中的HLA-G表达和NK敏感性。我们对三种黑色素瘤细胞系和离体活检的分析表明:(i)IGR和M74人类黑色素瘤细胞系表现出高水平的HLA-G转录,具有不同的HLA-G异构体转录和蛋白质表达模式;(ii)与来自同一个体的健康皮肤片段相比,在皮肤黑色素瘤转移活检中检测到离体时更高水平的HLA-G转录;(iii)除膜结合型HLA-G1外的其他HLA-G蛋白质异构体可保护IGR免受NK细胞裂解。因此,在未来癌症免疫疗法的设计中考虑HLA-G表达在肿瘤中的特定作用显得至关重要。